CN-21 RISK MODELING FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED ON RTOG 0825

BACKGROUND: TMZ is well tolerated with a relatively low incidence of myelotoxicity, which can nonetheless result in treatment delays or death. Our goal was to evaluate risk and validate prediction models in newly diagnosed patients treated with TMZ +/- bevacizumab (BEV). METHODS: Models (from recurr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Zhou, Renke, Scheurer, Michael, Vera-Bolanos, Elizabeth, Gilbert, Mark, Bondy, Melissa, Sulman, Eric, Hilsenbeck, Sue, Wendland, Merideth, Brachman, David, Roof, Kevin, Komaki, Ritsuko, Deutsch, Melvin, Andrews, David, Anderson, Bethany, Lee, R. Jeffrey, Pugh, Stephanie, Armstrong, Terri
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2014
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218016/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou243.21
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker